By Richard Lenti
A groundbreaking study using stem cells to treat multiple sclerosis (MS) has been approved by the Food and Drug Administration. If successful, scientists believe it may one day lead to a cure for the autoimmune system disease.
Researchers at the Tisch MS Research Center of New York say that approval of early clinical Phase I trials by the FDA comes after more than a decade of research.
“As important a milestone as the FDA investigational new drug approval is, it marks the true beginning and not the end of our clinical research of stem cell therapy,” wrote Tisch researchers in a statement announcing the trial.
“In this and subsequent studies, we hope to define the optimal therapeutic dose and dosing frequency of stem cells, the best route of administration, whether or not stem cells should be used in combination with other disease modifying treatments, and which patients are most likely to benefit from this treatment.”
Read more at National Pain Report.
(0) Readers Comments
November 12, 2012
October 08, 2012
September 12, 2012
July 23, 2012
June 11, 2019
April 01, 2019
March 18, 2019
Oh boy...Your right we hate to hear this. You know why people in pain
Doesn't the 1.5 billion is spent a year give credence to its possitive
Many MS drugs cause PML and deaths too these drugs all need t
I knew him when he was breaking in at a couple of Los Angeles TV stati
Saying there is a 'twist' is the worst type of spoile